How should I manage an elderly patient with a six‑week productive cough, poor oral intake, and diarrhea after a five‑day course of amoxicillin‑clavulanate (Augmentin)?

Management of Prolonged Productive Cough in an Elderly Patient After Failed Augmentin Therapy

Switch to a macrolide antibiotic (azithromycin or clarithromycin) as the most appropriate next step for this elderly patient with a 6-week productive cough who developed diarrhea after 5 days of amoxicillin-clavulanate. 1

Clinical Context and Diagnosis

This presentation represents subacute cough (lasting 3-8 weeks), most consistent with postinfectious cough following an acute respiratory infection 1. The 6-week duration places this squarely in the subacute category where postinfectious causes predominate, and the recent decline in oral intake raises concern for clinical deterioration requiring reassessment 1.

Key Pathophysiologic Considerations

Multiple factors contribute to postinfectious cough in this timeframe 1:

• Post-viral airway inflammation with bronchial hyperresponsiveness
• Mucus hypersecretion and impaired mucociliary clearance
• Possible atypical bacterial infection (Mycoplasma pneumoniae, Chlamydia pneumoniae)
• Upper airway cough syndrome (UACS)

Why Augmentin Failed and Caused Harm

Amoxicillin-clavulanate has a well-documented association with gastrointestinal adverse effects, particularly diarrhea 2, 3:

• The clavulanic acid component specifically causes diarrhea with a number needed to harm of 10 (95% CI 6-17) 3
• Amoxicillin-clavulanate increases small intestinal motility disturbances, particularly during nocturnal fasting periods 4
• The combination can cause ischemic colitis in rare cases 5
• Antibiotics have no role in postinfectious cough when bacterial sinusitis or Bordetella pertussis are not present 1

The 5-day course was inadequate even if bacterial infection were present, as most respiratory infections require at least 7 days of treatment 6.

Recommended Treatment Algorithm

First-Line Therapy: Macrolide Antibiotic

Prescribe azithromycin 500 mg on day 1, then 250 mg daily for days 2-5 1, 7:

• Covers atypical pathogens (Mycoplasma, Chlamydia) that may be contributing to persistent cough
• Better gastrointestinal tolerability than amoxicillin-clavulanate
• Shorter course improves compliance
• Alternative: clarithromycin 500 mg twice daily for 7-14 days 1, 6

Adjunctive Symptomatic Therapy

If cough persists despite macrolide therapy, consider sequential addition 1:

1. Inhaled ipratropium bromide - First-line symptomatic treatment for postinfectious cough (Level of evidence: fair; Grade B) 1

2. Inhaled corticosteroids - If cough adversely affects quality of life and persists despite ipratropium (Level of evidence: expert opinion; Grade E/B) 1

3. Short course of oral prednisone 30-40 mg daily - For severe paroxysms after ruling out other common causes like UACS, asthma, or GERD (Level of evidence: low; Grade C) 1

4. Central antitussives (codeine or dextromethorphan) - When other measures fail (Level of evidence: expert opinion; Grade E/B) 1

Critical Red Flags Requiring Immediate Investigation

Reassess for the following concerning features 8:

• Hemoptysis
• Smoker >45 years with new or changed cough
• Prominent dyspnea at rest or night
• Systemic symptoms (fever, weight loss beyond poor oral intake this week)
• Hoarseness or voice changes
• Recurrent pneumonia
• Abnormal respiratory examination

When to Consider Alternative Diagnoses

If no improvement after 8 weeks total duration, the diagnosis shifts from postinfectious cough to chronic cough, requiring evaluation for 1, 8:

• Upper airway cough syndrome (UACS/postnasal drip)
• Asthma or non-asthemic eosinophilic bronchitis
• Gastroesophageal reflux disease (GERD)
• Bronchiectasis (obtain HRCT scan)
• Tuberculosis (especially in endemic areas)
• Bordetella pertussis infection

Specific Consideration for Pertussis

If the patient has paroxysmal coughing, post-tussive vomiting, or inspiratory whooping, consider pertussis even at 6 weeks 1:

• Obtain nasopharyngeal aspirate or swab for culture and PCR
• Treat with a macrolide (erythromycin or azithromycin) for 5 days
• Isolate patient for 5 days from start of treatment
• Early treatment within first few weeks diminishes paroxysms; unlikely to respond beyond this period 9

Addressing Poor Oral Intake

The recent decline in oral intake requires attention 10:

• Assess for volume depletion
• Consider need for intravenous fluids if dehydration present
• Nutritional support may be needed if illness prolonged
• Monitor for clinical deterioration requiring hospitalization

Follow-Up Plan

Schedule reassessment in 2-3 days 11:

• Most patients with appropriate therapy show improvement within 48-72 hours
• If condition deteriorates or shows no improvement, further investigation is mandatory
• Chest radiograph indicated if not already obtained or if clinical deterioration occurs

If cough persists beyond 8 weeks total, transition to chronic cough evaluation algorithm with systematic assessment for UACS, asthma, and GERD 12, 8.

Common Pitfalls to Avoid

• Do not continue or restart amoxicillin-clavulanate given the documented intolerance and lack of indication for postinfectious cough 1, 2
• Do not use antibiotics routinely for acute/subacute bronchitis unless pertussis suspected 9
• Do not delay macrolide therapy if atypical infection suspected - the 6-week duration with productive cough supports this possibility 1
• Do not ignore the poor oral intake - this may signal clinical deterioration requiring more aggressive intervention 10